Iridex Corp. Company Profile (NASDAQ:IRIX)

About Iridex Corp.

Iridex Corp. logoIRIDEX Corporation is a provider of therapeutic based laser consoles, delivery devices and consumable instrumentation used to treat sight-threatening eye diseases in ophthalmology. The Company operates through ophthalmology segment. Its ophthalmology products consist of laser consoles, delivery devices and consumable instrumentation, including laser probes, and are used in the treatment of serious eye diseases, including the over three causes of irreversible blindness, such as diabetic retinopathy, glaucoma and age-related macular degeneration (AMD). In addition, the Company's ophthalmology products are often used in vitrectomy procedures (used to treat proliferative diabetic retinopathy, macular holes, retinal tears and detachments), which are generally performed in the operating room and require a consumable single use intraocular laser probe (EndoProbe) to deliver light to the back of the eye together with other instrumentation.

Industry, Sector and Symbol:
  • Sector: Computer and Technology
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: IRIX
  • CUSIP:
Key Metrics:
  • Previous Close: $14.89
  • 50 Day Moving Average: $15.31
  • 200 Day Moving Average: $12.61
  • Trailing P/E Ratio: 224.31
  • P/E Growth: -15.02
  • Market Cap: $147.52M
  • Outstanding Shares: 10,118,000
  • Beta: 0.73
Additional Links:
Companies Related to Iridex Corp.:

Analyst Ratings

Consensus Ratings for Iridex Corp. (NASDAQ:IRIX) (?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $11.50 (21.12% downside)

Analysts' Ratings History for Iridex Corp. (NASDAQ:IRIX)
Show:
DateFirmActionRatingPrice TargetDetails
1/26/2016Singular ResearchInitiated CoverageBuy$11.50View Rating Details
(Data available from 8/26/2014 forward)

Earnings

Earnings History for Iridex Corp. (NASDAQ:IRIX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/3/2016        
8/4/2016Q216$0.01($0.03)$11.90 million$11.90 millionViewListenView Earnings Details
5/5/2016Q116$0.04$0.01$11.88 million$11.90 millionViewListenView Earnings Details
3/3/2016Q415$0.04$0.04$11.80 million$12.10 millionViewListenView Earnings Details
11/5/2015Q315$0.04$10.10 million$9.80 millionViewListenView Earnings Details
8/6/2015Q215($0.07)$10.60 million$9.00 millionViewListenView Earnings Details
5/7/2015Q115$0.02$10.30 million$10.80 millionViewListenView Earnings Details
3/5/2015Q414$0.97$10.60 million$11.80 millionViewListenView Earnings Details
5/1/2014Q1$0.06$0.05$8.90 million$10.30 millionViewListenView Earnings Details
2/27/2014Q4$0.04$0.04ViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Iridex Corp. (NASDAQ:IRIX)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Iridex Corp. (NASDAQ:IRIX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Iridex Corp. (NASDAQ:IRIX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/23/2016Romeo R DizonInsiderSell875$14.52$12,705.00View SEC Filing  
8/19/2016Romeo R DizonInsiderSell7,896$13.52$106,753.92View SEC Filing  
8/16/2016George R MarcellinoDirectorSell2,513$13.57$34,101.41View SEC Filing  
8/16/2016Romeo R DizonInsiderSell839$13.70$11,494.30View SEC Filing  
6/6/2016Ronald SteckelVPSell625$13.52$8,450.00View SEC Filing  
5/17/2016Ronald SteckelVPSell4,583$12.81$58,708.23View SEC Filing  
3/8/2016Ronald SteckelVPSell12,000$10.45$125,400.00View SEC Filing  
11/19/2015William M MooreCEOBuy10,000$9.83$98,300.00View SEC Filing  
9/25/2015Associates & Paragon A ParagonMajor ShareholderBuy52,042$7.05$366,896.10View SEC Filing  
9/10/2015Associates & Paragon A ParagonMajor ShareholderBuy11,866$6.95$82,468.70View SEC Filing  
9/4/2015Associates & Paragon A ParagonMajor ShareholderBuy10,304$6.81$70,170.24View SEC Filing  
9/2/2015Ronald SteckelVPSell1,875$6.80$12,750.00View SEC Filing  
8/21/2015Associates & Paragon A ParagonMajor ShareholderBuy20,651$7.16$147,861.16View SEC Filing  
8/19/2015James H. MackanessCFOSell2,373$7.15$16,966.95View SEC Filing  
8/19/2015Ronald SteckelVPSell1,751$7.14$12,502.14View SEC Filing  
8/18/2015James H. MackanessCFOSell2,627$7.10$18,651.70View SEC Filing  
8/17/2015James H. MackanessCFOSell2,235$7.05$15,756.75View SEC Filing  
8/14/2015James H MackanessCFOSell7,765$6.99$54,277.35View SEC Filing  
8/14/2015Ronald SteckelVPSell1,458$7.00$10,206.00View SEC Filing  
7/24/2015Associates & Paragon A ParagonMajor ShareholderBuy40,403$7.01$283,225.03View SEC Filing  
6/17/2015Ronald SteckelVPSell1,666$8.77$14,610.82View SEC Filing  
5/20/2015James H MackanessCFOSell2,000$9.80$19,600.00View SEC Filing  
5/18/2015Ronald SteckelVPSell1,667$9.33$15,553.11View SEC Filing  
4/20/2015Ronald SteckelVPSell1,447$9.79$14,166.13View SEC Filing  
4/17/2015Ronald SteckelVPSell1,667$9.86$16,436.62View SEC Filing  
3/17/2015Ronald SteckelVPSell11,358$10.08$114,488.64View SEC Filing  
3/10/2015Ronald SteckelVPSell1,250$10.03$12,537.50View SEC Filing  
2/17/2015Ronald SteckelVPSell1,650$9.79$16,153.50View SEC Filing  
1/20/2015Ronald SteckelVPSell1,650$9.03$14,899.50View SEC Filing  
12/17/2014Ronald SteckelVPSell1,650$8.52$14,058.00View SEC Filing  
11/17/2014Ronald SteckelVPSell1,650$8.28$13,662.00View SEC Filing  
11/6/2014William M MooreDirectorBuy5,000$7.79$38,950.00View SEC Filing  
10/12/2014Catalyst Fund Ix L.P BluelineDirectorBuy17,237$8.11$139,792.07View SEC Filing  
10/10/2014Catalyst Fund Ix L.P BluelineDirectorBuy12,798$8.02$102,639.96View SEC Filing  
9/5/2014Catalyst Fund Ix L.P BluelineDirectorBuy8,432$7.99$67,371.68View SEC Filing  
8/29/2014Catalyst Fund Ix L.P BluelineDirectorBuy4,272$7.92$33,834.24View SEC Filing  
8/22/2014James B HawkinsDirectorSell600$8.03$4,818.00View SEC Filing  
8/18/2014Ronald SteckelVPSell1,650$8.00$13,200.00View SEC Filing  
8/15/2014James B HawkinsDirectorSell14,400$8.10$116,640.00View SEC Filing  
8/14/2014James B HawkinsDirectorSell2,714$8.08$21,929.12View SEC Filing  
8/13/2014James B HawkinsDirectorSell9,786$8.11$79,364.46View SEC Filing  
8/11/2014Garrett A GarrettsonDirectorSell2,810$8.30$23,323.00View SEC Filing  
7/31/2014Ronald SteckelVPSell761$8.00$6,088.00View SEC Filing  
7/21/2014James H MackanessCFOSell1,000$7.62$7,620.00View SEC Filing  
6/23/2014James H MackanessCFOSell2,000$8.24$16,480.00View SEC Filing  
6/17/2014Ronald SteckelVPSell1,650$8.20$13,530.00View SEC Filing  
6/6/2014Catalyst Fund Ix L.P BluelineDirectorBuy7,390$8.32$61,484.80View SEC Filing  
6/3/2014William M MooreCEOBuy5,000$8.48$42,400.00View SEC Filing  
5/21/2014James H MackanessCFOSell3,000$8.73$26,190.00View SEC Filing  
5/19/2014Ronald SteckelVPSell1,650$8.82$14,553.00View SEC Filing  
5/9/2014William M MooreCEOBuy5,000$8.40$42,000.00View SEC Filing  
4/22/2014James H MackanessCFOSell4,000$8.74$34,960.00View SEC Filing  
4/17/2014Ronald SteckelVPSell1,650$8.88$14,652.00View SEC Filing  
3/21/2014James H MackanessCFOSell4,000$9.03$36,120.00View SEC Filing  
3/17/2014Ronald SteckelVPSell1,650$9.07$14,965.50View SEC Filing  
2/18/2014Ronald SteckelVPSell1,650$8.60$14,190.00View SEC Filing  
1/17/2014Ronald SteckelVPSell1,650$10.42$17,193.00View SEC Filing  
12/17/2013Ronald SteckelVPSell1,650$8.56$14,124.00View SEC Filing  
12/2/2013James H MackanessCFOSell10,000$10.52$105,200.00View SEC Filing  
9/6/2013Ruediger Naumann-EtienneDirectorBuy3,600$5.99$21,564.00View SEC Filing  
8/9/2013William M MooreCEOBuy10,000$5.88$58,800.00View SEC Filing  
6/19/2013Eduardo AriasVPSell22,768$5.43$123,630.24View SEC Filing  
6/18/2013James H MackanessCFOSell19,862$4.58$90,967.96View SEC Filing  
6/17/2013Eduardo AriasVPSell4,532$5.39$24,427.48View SEC Filing  
6/14/2013James H MackanessCFOSell10,568$5.38$56,855.84View SEC Filing  
6/13/2013James H MackanessCFOSell1,400$5.30$7,420.00View SEC Filing  
6/11/2013Eduardo AriasVPSell1,000$5.61$5,610.00View SEC Filing  
6/11/2013James H MackanessCFOSell1,200$5.61$6,732.00View SEC Filing  
6/10/2013Eduardo AriasVPSell2,400$5.38$12,912.00View SEC Filing  
6/10/2013James H MackanessCFOSell6,970$5.36$37,359.20View SEC Filing  
6/6/2013William M MooreCEOBuy2,000$5.42$10,840.00View SEC Filing  
5/17/2013Eduardo AriasVPSell10,000$6.30$63,000.00View SEC Filing  
3/8/2013Ruediger Naumann-EtienneDirectorBuy2,400$4.80$11,520.00View SEC Filing  
3/7/2013William M MooreCEOBuy10,000$4.66$46,600.00View SEC Filing  
9/6/2012William M MooreCEOBuy10,000$3.76$37,600.00View SEC Filing  
8/15/2012Catalyst Fund Ix L.P BluelineMajor ShareholderBuy60,900$3.19$194,271.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Iridex Corp. (NASDAQ:IRIX)
DateHeadline
capitalcube.com logoETF’s with exposure to IRIDEX Corp. : August 24, 2016 (NASDAQ:IRIX)
www.capitalcube.com - August 24 at 5:34 PM
News IconPrincipal Accounting Officer of IRIDEX Corporation (NASDAQ:IRIX), Dizon Romeo R, sells 1,690 shares worth $22,817 (NASDAQ:IRIX)
empowerednews.net - August 23 at 5:53 PM
finance.yahoo.com logoEdited Transcript of IRIX earnings conference call or presentation 4-Aug-16 9:00pm GMT (NASDAQ:IRIX)
finance.yahoo.com - August 15 at 9:16 PM
capitalcube.com logoIRIDEX Corp. :IRIX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 15, 2016 (NASDAQ:IRIX)
www.capitalcube.com - August 15 at 3:49 PM
mysmartrend.com logoIridex Has Returned 51.7% Since SmarTrend Recommendation (IRIX) (NASDAQ:IRIX)
www.mysmartrend.com - August 9 at 5:50 PM
twst.com logoIRIDEX Corporation: IRIDEX Reports 2016 Second Quarter, Six-Month Results (NASDAQ:IRIX)
www.twst.com - August 5 at 8:44 AM
sg.finance.yahoo.com logoIridex reports 2Q loss (NASDAQ:IRIX)
sg.finance.yahoo.com - August 5 at 8:44 AM
biz.yahoo.com logoQ2 2016 IRIDEX Corp Earnings Release - After Market Close (NASDAQ:IRIX)
biz.yahoo.com - August 4 at 8:44 AM
publicnow.com logoIRIDEX Announces Second Quarter 2016 Conference Call and Release Date (NASDAQ:IRIX)
www.publicnow.com - July 28 at 4:18 PM
capitalcube.com logoETF’s with exposure to IRIDEX Corp. : July 21, 2016 (NASDAQ:IRIX)
www.capitalcube.com - July 21 at 2:09 PM
biz.yahoo.com logoIRIDEX CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definitive Agre (NASDAQ:IRIX)
biz.yahoo.com - July 11 at 4:17 PM
publicnow.com logoIRIDEX Announces Atabak Mokari Will Be Chief Financial Officer And VP Corporate Development (NASDAQ:IRIX)
www.publicnow.com - July 11 at 7:03 AM
biz.yahoo.com logoIRIDEX CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders (NASDAQ:IRIX)
biz.yahoo.com - June 21 at 4:17 PM
publicnow.com logoIRIDEX to Present at the Singular Research 11th Annual Best of the Uncovereds Spring Select Conference (NASDAQ:IRIX)
www.publicnow.com - June 2 at 4:35 PM
fxpips.com logoInvestors’ Pick for May 20 – PQ, AQMS, BRC, IRIX, USMD, DWSN, UNB (NASDAQ:IRIX)
www.fxpips.com - May 20 at 11:43 AM
capitalcube.com logoIRIDEX Corp. :IRIX-US: Earnings Analysis: Q1, 2016 By the Numbers (NASDAQ:IRIX)
www.capitalcube.com - May 11 at 11:57 AM
publicnow.com logoIRIDEX Announces Cyclo G6™ with MicroPulse® P3 Clinical Data Presented at ARVO and ASCRS Annual Meetings (NASDAQ:IRIX)
www.publicnow.com - May 10 at 7:18 AM
sg.finance.yahoo.com logoIridex posts 1Q profit (NASDAQ:IRIX)
sg.finance.yahoo.com - May 5 at 6:24 PM
finance.yahoo.com logoIRIDEX Reports 2016 First Quarter Results (NASDAQ:IRIX)
finance.yahoo.com - May 5 at 4:05 PM
biz.yahoo.com logoQ1 2016 IRIDEX Corp Earnings Release - After Market Close (NASDAQ:IRIX)
biz.yahoo.com - May 5 at 7:07 AM
publicnow.com logoIRIDEX Announces First Quarter 2016 Conference Call and Release Date (NASDAQ:IRIX)
www.publicnow.com - April 28 at 4:36 PM
biz.yahoo.com logoIRIDEX CORP Files SEC form 10-K, Annual Report (NASDAQ:IRIX)
biz.yahoo.com - March 31 at 5:20 PM
publicnow.com logoIRIDEX Gains Patent Approvals Covering TxCell™-Guided MicroPulse® Laser Therapy; Predictably Enables Faster, Durable Treatments for Glaucoma and Retinal Diseases (NASDAQ:IRIX)
www.publicnow.com - March 22 at 4:31 PM
finance.yahoo.com logo4:07 pm IRIDEX gains 2 patent approvals covering TXcell-guided micropulse laser therapy, enables treatments for glaucoma and retinal diseases (NASDAQ:IRIX)
finance.yahoo.com - March 22 at 4:07 PM
capitalcube.com logoETF’s with exposure to IRIDEX Corp. : March 10, 2016 (NASDAQ:IRIX)
www.capitalcube.com - March 10 at 1:54 PM
capitalcube.com logoIRIDEX Corp. :IRIX-US: Earnings Analysis: 2015 By the Numbers (NASDAQ:IRIX)
www.capitalcube.com - March 9 at 12:03 PM
biz.yahoo.com logoIRIDEX CORP Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:IRIX)
biz.yahoo.com - March 7 at 5:17 PM
finance.yahoo.com logoEdited Transcript of IRIX earnings conference call or presentation 3-Mar-16 10:00pm GMT (NASDAQ:IRIX)
finance.yahoo.com - March 4 at 2:47 PM
sg.finance.yahoo.com logoIridex posts 4Q profit (NASDAQ:IRIX)
sg.finance.yahoo.com - March 3 at 5:20 PM
biz.yahoo.com logoIRIDEX Corp Earnings Call scheduled for 5:00 pm ET today (NASDAQ:IRIX)
biz.yahoo.com - March 3 at 5:00 PM
finance.yahoo.com logoIRIDEX Reports 2015 Fourth Quarter, Full Year Results (NASDAQ:IRIX)
finance.yahoo.com - March 3 at 4:05 PM
biz.yahoo.com logoQ4 2015 IRIDEX Corp Earnings Release - After Market Close (NASDAQ:IRIX)
biz.yahoo.com - March 3 at 7:07 AM
finance.yahoo.com logoIRIDEX Receives CE Mark for Cyclo G6™ Laser System for the Treatment of Multiple Stages of Glaucoma (NASDAQ:IRIX)
finance.yahoo.com - February 16 at 6:30 AM
finance.yahoo.com logoCoverage initiated on IRIDEX by Singular Research (NASDAQ:IRIX)
finance.yahoo.com - January 26 at 2:15 PM
biz.yahoo.com logoIRIDEX CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (NASDAQ:IRIX)
biz.yahoo.com - January 12 at 4:04 PM
biz.yahoo.com logoIRIDEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (NASDAQ:IRIX)
biz.yahoo.com - January 11 at 4:04 PM
noodls.com logoIRIDEX Announces Preliminary Unaudited Revenues for 2015 Fourth Quarter and Full Year (NASDAQ:IRIX)
www.noodls.com - January 11 at 6:47 AM
finance.yahoo.com logoEdited Transcript of IRIX earnings conference call or presentation 5-Nov-15 10:00pm GMT (NASDAQ:IRIX)
finance.yahoo.com - January 8 at 12:00 PM
capitalcube.com logoIRIDEX Corp. Earnings Analysis: Q3, 2015 By the Numbers (NASDAQ:IRIX)
www.capitalcube.com - December 21 at 12:24 PM
finance.yahoo.com logoIRIDEX CORP Financials (NASDAQ:IRIX)
finance.yahoo.com - December 8 at 1:17 PM
finance.yahoo.com logoTechnical Movement Driving Equities - Research on BIND Therapeutics, Edgewater Technology, IRIDEX, and PRGX Global (NASDAQ:IRIX)
finance.yahoo.com - December 2 at 8:30 AM
insidermonkey.com logoDo Hedge Funds Love IRIDEX Corporation (IRIX)? (NASDAQ:IRIX)
www.insidermonkey.com - December 1 at 5:29 PM
noodls.com logoIRIDEX to Showcase Cyclo G6™ Laser System Equipped with MicroPulse® Tissue Sparing Glaucoma Technology at American Academy of Ophthalmology (AAO) Meeting (NASDAQ:IRIX)
www.noodls.com - November 11 at 6:56 AM
biz.yahoo.com logoIRIDEX CORP Files SEC form 10-Q, Quarterly Report (NASDAQ:IRIX)
biz.yahoo.com - November 10 at 5:05 PM
sg.finance.yahoo.com logoIridex posts 3Q profit (NASDAQ:IRIX)
sg.finance.yahoo.com - November 5 at 6:48 PM

Social

Iridex Corp. (NASDAQ:IRIX) Chart for Friday, August, 26, 2016


Last Updated on 8/26/2016 by MarketBeat.com Staff